These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 15870939

  • 1. [99mTc] HYNIC-hEGF, a potential agent for imaging of EGF receptors in vivo: preparation and pre-clinical evaluation.
    Babaei MH, Almqvist Y, Orlova A, Shafii M, Kairemo K, Tolmachev V.
    Oncol Rep; 2005 Jun; 13(6):1169-75. PubMed ID: 15870939
    [Abstract] [Full Text] [Related]

  • 2. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
    von Guggenberg E, Behe M, Behr TM, Saurer M, Seppi T, Decristoforo C.
    Bioconjug Chem; 2004 Jun; 15(4):864-71. PubMed ID: 15264875
    [Abstract] [Full Text] [Related]

  • 3. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
    Yu F, Lü ML, Zhang XP, Fu D, Hou M, Cai HD, Li D, Wang J, Yuan XY, Lü ZW, Dong F.
    Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936
    [Abstract] [Full Text] [Related]

  • 4. 99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand.
    Wang J, Kim YS, Liu S.
    Bioconjug Chem; 2008 Mar; 19(3):634-42. PubMed ID: 18281926
    [Abstract] [Full Text] [Related]

  • 5. In vitro cell studies of technetium-99m labeled RGD-HYNIC peptide, a comparison of tricine and EDDA as co-ligands.
    Su ZF, He J, Rusckowski M, Hnatowich DJ.
    Nucl Med Biol; 2003 Feb; 30(2):141-9. PubMed ID: 12623113
    [Abstract] [Full Text] [Related]

  • 6. Synthesis of oxytocin HYNIC derivatives as potential diagnostic agents for breast cancer.
    Miranda-Olvera AD, Ferro-Flores G, Pedraza-López M, de Murphy CA, De León-Rodríguez LM.
    Bioconjug Chem; 2007 Feb; 18(5):1560-7. PubMed ID: 17665873
    [Abstract] [Full Text] [Related]

  • 7. In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
    Yurt Lambrecht F, Durkan K, Ozgür A, Gündüz C, Avcı CB, Susluer SY.
    J Drug Target; 2013 May; 21(4):383-8. PubMed ID: 23301856
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging.
    Garcia MF, Zhang X, Gallazzi F, Fernandez M, Moreno M, Gambini JP, Porcal W, Cabral P, Quinn TP.
    Anticancer Agents Med Chem; 2015 May; 15(1):122-30. PubMed ID: 25175799
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO, Huang L, Caveliers V, Keyaerts M, Hernot S, Vaneycken I, Vanhove C, Revets H, De Baetselier P, Lahoutte T.
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [Abstract] [Full Text] [Related]

  • 10. Imaging epidermal growth factor receptor expression in vivo: pharmacokinetic and biodistribution characterization of a bioconjugated quantum dot nanoprobe.
    Diagaradjane P, Orenstein-Cardona JM, Colón-Casasnovas NE, Deorukhkar A, Shentu S, Kuno N, Schwartz DL, Gelovani JG, Krishnan S.
    Clin Cancer Res; 2008 Feb 01; 14(3):731-41. PubMed ID: 18245533
    [Abstract] [Full Text] [Related]

  • 11. Technetium-99m-labeling and synthesis of thymidine analogs: potential candidates for tumor imaging.
    Teng B, Bai Y, Chang Y, Chen S, Li Z.
    Bioorg Med Chem Lett; 2007 Jun 15; 17(12):3440-4. PubMed ID: 17449246
    [Abstract] [Full Text] [Related]

  • 12. An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers.
    Varmira K, Hosseinimehr SJ, Noaparast Z, Abedi SM.
    J Drug Target; 2014 Feb 15; 22(2):116-22. PubMed ID: 24098950
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. N,N-bis(2-mercaptoethyl)methylamine: a new coligand for Tc-99m labeling of hydrazinonicotinamide peptides.
    Banerjee SR, Maresca KP, Stephenson KA, Valliant JF, Babich JW, Graham WA, Barzana M, Dong Q, Fischman AJ, Zubieta J.
    Bioconjug Chem; 2005 Feb 15; 16(4):885-902. PubMed ID: 16029030
    [Abstract] [Full Text] [Related]

  • 18. Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.
    Velikyan I, Sundberg AL, Lindhe O, Höglund AU, Eriksson O, Werner E, Carlsson J, Bergström M, Långström B, Tolmachev V.
    J Nucl Med; 2005 Nov 15; 46(11):1881-8. PubMed ID: 16269603
    [Abstract] [Full Text] [Related]

  • 19. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity.
    Iyer AK, Tran KT, Borysenko CW, Cascio M, Camacho CJ, Blair HC, Bahar I, Wells A.
    J Cell Physiol; 2007 Jun 15; 211(3):748-58. PubMed ID: 17311283
    [Abstract] [Full Text] [Related]

  • 20. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C, Klasmeyer K, Bojar H, Schulz WA, Ackermann R, Grimm MO.
    Cancer; 2007 May 15; 109(10):2016-24. PubMed ID: 17394193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.